These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2859624)

  • 81. Asparagus P(R) cannot compete with first-line diuretics in lowering the blood pressure in treatment-requiring antihypertensives.
    Chrubasik S; Droste C; Black A
    Phytother Res; 2009 Sep; 23(9):1345-6. PubMed ID: 19274702
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Interrelations between work capacity and the indicators of central and cerebral hemodynamics in patients with hypertension during hypotensive treatment].
    Sidorenko GI; Pavlova AI; Nechesova TA; Gaĭduk VN; Atroshchenko IE
    Kardiologiia; 1985 Oct; 25(10):104-7. PubMed ID: 2868146
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The role of adrenergic drugs in antihypertensive therapy.
    Itskovitz HD
    Cleve Clin J Med; 1991; 58(1):79-93. PubMed ID: 2070522
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antihypertensive effects of beta-blockers in hypertensive rats.
    Takeda K; Sakurai H; Imai S
    Jpn J Pharmacol; 1975 Feb; 25(1):82-3. PubMed ID: 239268
    [No Abstract]   [Full Text] [Related]  

  • 85. The management of hypertension.
    Aagaard GN
    JAMA; 1973 Apr; 224(3):329-32. PubMed ID: 4739534
    [No Abstract]   [Full Text] [Related]  

  • 86. Oxprenolol in the treatment of hypertension in the elderly.
    Taylor SH
    Am J Cardiol; 1983 Nov; 52(9):57D-61D. PubMed ID: 6139012
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Drug utilization data in risk/benefit analyses of drugs--benefit analysis.
    Gross FH
    Acta Med Scand Suppl; 1984; 683():141-7. PubMed ID: 6146248
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A different approach to resistant hypertension.
    Hirsch S
    Cleve Clin J Med; 2007 Jun; 74(6):449-56. PubMed ID: 17569203
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Combined treatment with hydrazinophthalazines and beta sympatholytic agents of nephrogenic hypertension].
    Zabicka H; Chrzanowski W; Kubala L; Orlowski Z
    Pol Tyg Lek; 1976 Dec; 31(52):2209-11. PubMed ID: 12500
    [No Abstract]   [Full Text] [Related]  

  • 90. [The characteristics of the physical training for therapy of hypertension].
    Nomura G
    Nihon Rinsho; 1992 May; 50 Suppl():168-73. PubMed ID: 1512953
    [No Abstract]   [Full Text] [Related]  

  • 91. [Pharmacoeconomical aspects of the use of beta-blockers in hypertension and heart failure].
    Ostroumova OD; Mamaev VI; Ishchenko KA; Shorikova EG
    Kardiologiia; 2003; 43(5):87-96. PubMed ID: 12942933
    [No Abstract]   [Full Text] [Related]  

  • 92. Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator.
    Breen EG; Mulhall D; Keogh JA
    Eur J Clin Pharmacol; 1985; 28(4):381-6. PubMed ID: 4029244
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Individualized hypertension therapy. An alternative to stepped-care treatment.
    Schoenberger JA
    Postgrad Med; 1987 May; 81(7):92-5, 99-100. PubMed ID: 2883642
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Drug therapy of chronic coronary insufficiency].
    Witchitz S; Weber S; Arich C
    Rev Prat; 1977 Oct; 27(47):3111-26. PubMed ID: 23579
    [No Abstract]   [Full Text] [Related]  

  • 95. Effects of various drug regimens.
    Littler WA
    Hypertension; 1984; 6(6 Pt 2):III179-84. PubMed ID: 6151550
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Consumption of coronary vasodilator agents and beta blockaders in 2 Prague districts].
    Balda L; Mikolásek A; Kubát K; Kratochvíl J; Stika L
    Cesk Zdrav; 1977 May; 25(5):201-6. PubMed ID: 16700
    [No Abstract]   [Full Text] [Related]  

  • 97. [Treatment of hypertension in patients with renal dialysis].
    Zidek W
    MMW Fortschr Med; 2008 Apr; 150(15):37-8. PubMed ID: 18510116
    [No Abstract]   [Full Text] [Related]  

  • 98. Therapy of mild hypertension: an overview.
    Kaplan NM
    Am J Cardiol; 1984 Jan; 53(3):2A-8A. PubMed ID: 6141722
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Hypertension in the malignant phase: some current aspects of physiopathology and therapy].
    Amato M; Bertoni E; Forti G; Salvadori M; Sodi A; Constantini A
    Recenti Prog Med; 1977 Jul; 63(1):13-20. PubMed ID: 578580
    [No Abstract]   [Full Text] [Related]  

  • 100. The current status of beta blockers' use in the management of hypertension.
    Akbar S; Alorainy MS
    Saudi Med J; 2014 Nov; 35(11):1307-17. PubMed ID: 25399206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.